Chuck Collins

Company: The HSS Group

Job title: Independent Consultant

Seminars:

Roundtable Discussion: Specialty vs. Retail Pharmacies in CNS Therapeutics – Navigating Access, Margins, & Patient Support 1:00 pm

How shrinking margins, generics, and store closures have impacted retail’s role in CNS therapy access, and why it’s becoming less viable for novel treatments The growing importance of specialty pharmacies for large-molecule and complex CNS drugs, and their role in delivering enhanced services like prior authorization and assignment of benefits Strategic considerations for manufacturers in…Read more

day: Conference Day One

Panel Discussion: From Policy to Practice – Bridging the Gap Between Payer Access & Clinical Reality 1:30 pm

Explore how mismatches between labelled indication and payer policy (e.g., differing “line of therapy” requirements across insurers and states) create treatment denial risks and force patients or physicians into appeal processes, especially for time-sensitive psychiatric interventions The gap between contracted payer coverage and real-world access: address claim denials, administrative friction, and the need for improved…Read more

day: Conference Day One